Auditory Nerve Degeneration and Repair

听觉神经退化与修复

基本信息

  • 批准号:
    8370280
  • 负责人:
  • 金额:
    $ 36.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-10 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Degeneration of spiral ganglion neurons (SGNs) results in permanent sensorineural hearing loss (SNHL) and is irreversible. Transplantation of exogenous neural stem cells (NSCs) offers a promising therapeutic strategy for the treatment of a variety of neural degenerative disorders including SNHL. However, studies of various animal models of neurodegenerative diseases indicate that the time window for the successful transplantation of NSCs after injury is narrow, and that long-term survival and functional integration of NSCs is limited, particularly, in the chronically degenerated host environment. Despite the assumption that a favorable microenvironment is required for the survival and appropriate differentiation of NSCs after transplantation, little attention has been paid to exactl how the host microenvironment affects the behavior of transplanted NSCs. To address this gap, we have documented that survival of transplanted NSCs is significantly greater in the injured auditory nerve at early post-injury intervals compared to later post-injury intervals using a well-characterized animal model of ouabain-induced acute SGN injury. More recently, we have shown that acute SGN injury induces up-regulation of Sox2, a transcription factor that is highly expressed in undifferentiated neural cells during development and adult neurogenesis and gliogenesis. This up-regulation, along with the proliferation of Sox2+ glial cells in the injured adult auditory nerve, suggests that mature glial cells can revert to a less differentiated phenotype and re-enter the cell cycle in response to acute SGN injury. Based on these new findings, we hypothesize that SGN injury stimulates the quiescent glial cells to undergo a phenotypic transformation resulting in a microenvironment more conducive to the survival and differentiation of transplanted NSCs. The objective of this project is to determine the role of the host microenvironment, with a focus on endogenous glial cells, in regulating the survival and differentiation of transplanted NSCs. We will characterize phenotypic changes of glial cells in response to acute SGN injury (Aim 1); determine the mechanisms whereby acute injury-induced glial phenotypic changes mediate NSC survival and differentiation in vitro (Aim 2); and determine the ability of de-differentiated glial cells to influence the survival, neuronal differentiation and morphological integration of transplanted NSCs in vivo (Aim 3). The proposed experiments will reveal 1) the key molecular factors associated with glial cell phenotypic changes in response to SGN injury and 2) the molecular mechanisms promoting the survival of transplanted NSCs by de-differentiated glial cells. Such data will provide answers to basic questions about glial cell biology and establish in vitro and in vivo models for studies of glial cells in the auditory system. In addition, information obtained will be of great public health interest for the design of therapeutic strategies for SNHL and other neurodegenerative disorders using glial cells as targets. PUBLIC HEALTH RELEVANCE: The proposed studies will provide new knowledge of how changes in the microenvironment of the inner ear influence the outcome of stem cell transplantation. In particular, we will establish the critical roles glial cells play in regulatingthe survival and development of the transplanted stem cells. Such knowledge will impact the design of efficient therapies for sensorineural hearing loss and other neurodegenerative disorders using glial cells as targets.
描述(由申请人提供):螺旋神经节神经元(SGN)变性导致永久性感音神经性听力损失(SNHL),并且是不可逆的。外源性神经干细胞(NSCs)移植为治疗包括SNHL在内的多种神经退行性疾病提供了一种有前途的治疗策略。然而,对神经退行性疾病的各种动物模型的研究表明,损伤后成功移植NSC的时间窗很窄,并且NSC的长期存活和功能整合受到限制,特别是在慢性退化的宿主环境中。尽管假设移植后神经干细胞的存活和适当分化需要有利的微环境,但很少注意宿主微环境如何影响移植的神经干细胞的行为。为了解决这一差距,我们已经证明,移植的神经干细胞的存活率显着更大的损伤后的早期损伤后的时间间隔相比,损伤后的时间间隔使用哇巴因诱导的急性SGN损伤的动物模型。最近,我们已经表明,急性SGN损伤诱导Sox 2的上调,Sox 2是一种在发育和成体神经发生和胶质细胞发生过程中在未分化神经细胞中高度表达的转录因子。这种上调,沿着Sox 2+神经胶质细胞在损伤的成年听神经中的增殖,表明成熟的神经胶质细胞可以回复到分化程度较低的表型,并响应于急性SGN损伤重新进入细胞周期。基于这些新的发现,我们假设SGN损伤刺激静止的神经胶质细胞进行表型转化,从而产生更有利于移植的NSC的存活和分化的微环境。本项目的目标是确定 宿主微环境,重点是内源性胶质细胞,在调节移植的神经干细胞的存活和分化。我们将描述神经胶质细胞对急性SGN损伤的表型变化(目标1);确定急性损伤诱导的神经胶质细胞表型变化介导体外NSC存活和分化的机制(目标2);并确定去分化的神经胶质细胞影响体内移植的神经干细胞的存活、神经元分化和形态整合的能力(目标3)。所提出的实验将揭示1)与响应SGN损伤的神经胶质细胞表型变化相关的关键分子因子和2)通过去分化神经胶质细胞促进移植的NSC存活的分子机制。这些数据将提供有关神经胶质细胞生物学的基本问题的答案,并建立在体外和体内模型的神经胶质细胞在听觉系统的研究。此外,获得的信息将是巨大的公共卫生利益的SNHL和其他神经退行性疾病的治疗策略的设计使用神经胶质细胞作为目标。 公共卫生相关性:拟议的研究将为内耳微环境的变化如何影响干细胞移植的结果提供新的知识。特别是,我们将建立神经胶质细胞在调节移植干细胞的存活和发育中的关键作用。这些知识将影响使用神经胶质细胞作为靶点的感音神经性听力损失和其他神经退行性疾病的有效疗法的设计。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hainan Lang其他文献

Hainan Lang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hainan Lang', 18)}}的其他基金

Peripheral auditory system deficits and autism-like behaviors
周围听觉系统缺陷和自闭症样行为
  • 批准号:
    10187095
  • 财政年份:
    2021
  • 资助金额:
    $ 36.88万
  • 项目类别:
Peripheral auditory system deficits and autism-like behaviors
周围听觉系统缺陷和自闭症样行为
  • 批准号:
    10349592
  • 财政年份:
    2021
  • 资助金额:
    $ 36.88万
  • 项目类别:
Auditory Nerve Degeneration and Repair
听觉神经退化与修复
  • 批准号:
    8681418
  • 财政年份:
    2012
  • 资助金额:
    $ 36.88万
  • 项目类别:
Auditory Nerve Degeneration and Repair
听觉神经退化与修复
  • 批准号:
    8507714
  • 财政年份:
    2012
  • 资助金额:
    $ 36.88万
  • 项目类别:
Auditory Nerve Degeneration and Repair
听觉神经退化与修复
  • 批准号:
    9088445
  • 财政年份:
    2012
  • 资助金额:
    $ 36.88万
  • 项目类别:
Auditory Nerve Degeneration and Repair
听觉神经退化与修复
  • 批准号:
    9211519
  • 财政年份:
    2012
  • 资助金额:
    $ 36.88万
  • 项目类别:
Cell survival and cell death in the auditory nerve
听神经中的细胞存活和细胞死亡
  • 批准号:
    7178505
  • 财政年份:
    2006
  • 资助金额:
    $ 36.88万
  • 项目类别:
Cell survival and cell death in the auditory nerve
听神经中的细胞存活和细胞死亡
  • 批准号:
    7352782
  • 财政年份:
    2006
  • 资助金额:
    $ 36.88万
  • 项目类别:
Cell survival and cell death in the auditory nerve
听神经中的细胞存活和细胞死亡
  • 批准号:
    7035117
  • 财政年份:
    2006
  • 资助金额:
    $ 36.88万
  • 项目类别:
Project 2: Mechanistic studies of age-related hearing loss using animal models and human tissue
项目2:利用动物模型和人体组织研究年龄相关性听力损失的机制
  • 批准号:
    10675667
  • 财政年份:
    1997
  • 资助金额:
    $ 36.88万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.88万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.88万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 36.88万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.88万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.88万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.88万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.88万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 36.88万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 36.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 36.88万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了